Goldman Sachs’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,567
| Closed | -$16.7K | – | 5486 |
|
|
2025
Q1 | $16.7K | Sell |
31,567
-3
| -0% | -$2 | ﹤0.01% | 4985 |
|
|
2024
Q4 | $166K | Sell |
31,570
-1
| -0% | -$5 | ﹤0.01% | 4704 |
|
|
2024
Q3 | $452K | Hold |
31,571
| – | – | ﹤0.01% | 4158 |
|
|
2024
Q2 | $511K | Sell |
31,571
-4
| -0% | -$65 | ﹤0.01% | 3949 |
|
|
2024
Q1 | $3.2M | Sell |
31,575
-53,908
| -63% | -$5.46M | ﹤0.01% | 2898 |
|
|
2023
Q4 | $2.02M | Sell |
85,483
-17,663
| -17% | -$417K | ﹤0.01% | 3207 |
|
|
2023
Q3 | $2.08M | Sell |
103,146
-2
| -0% | -$40 | ﹤0.01% | 3073 |
|
|
2023
Q2 | $2.68M | Sell |
103,148
-97
| -0.1% | -$2.52K | ﹤0.01% | 3015 |
|
|
2023
Q1 | $2.15M | Sell |
103,245
-469
| -0.5% | -$9.76K | ﹤0.01% | 3163 |
|
|
2022
Q4 | $2.12M | Buy |
103,714
+103,019
| +14,823% | +$2.1M | ﹤0.01% | 3246 |
|
|
2022
Q3 | $19K | Sell |
695
-1,111
| -62% | -$30.4K | ﹤0.01% | 5181 |
|
|
2022
Q2 | $48K | Buy |
1,806
+316
| +21% | +$8.4K | ﹤0.01% | 5288 |
|
|
2022
Q1 | $119K | Buy |
+1,490
| New | +$119K | ﹤0.01% | 5256 |
|